BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Orsolini L, Sarchione F, Vellante F, Fornaro M, Matarazzo I, Martinotti G, Valchera A, Di Nicola M, Carano A, Di Giannantonio M, Perna G, Olivieri L, De Berardis D. Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review. Curr Neuropharmacol 2018;16:583-606. [PMID: 29357805 DOI: 10.2174/1570159X16666180119144538] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Garés-caballer M, Sánchez-ortí JV, Correa-ghisays P, Balanzá-martínez V, Selva-vera G, Vila-francés J, Magdalena-benedito R, San-martin C, Victor VM, Escribano-lopez I, Hernandez-mijares A, Vivas-lalinde J, Vieta E, Leza JC, Tabarés-seisdedos R. Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study. Front Neurol 2022;13:883927. [DOI: 10.3389/fneur.2022.883927] [Reference Citation Analysis]
2 Tong Z, Zhu J, Wang J, Yang Y, Hu W, Singh A. The Neutrophil-Lymphocyte Ratio Is Positively Correlated with Aggression in Schizophrenia. BioMed Research International 2022;2022:1-7. [DOI: 10.1155/2022/4040974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Li C, Shi Z, Ji J, Niu G, Liu Z. Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study. Neuropsychiatr Dis Treat 2021;17:2575-85. [PMID: 34408419 DOI: 10.2147/NDT.S322005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kim E, Kim Y. Immunomodulatory Effects of Antipsychotic Drugs in Whole Blood Cell Cultures from Healthy Subjects. CPRR 2020;15:261-6. [DOI: 10.2174/2666082215666191018160333] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 He X, Ma Q, Fan Y, Zhao B, Wang W, Zhu F, Ma X, Zhou L. The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia. Neuropsychiatr Dis Treat 2020;16:191-9. [PMID: 32021213 DOI: 10.2147/NDT.S218483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
6 Lin P, Sun J, Lou X, Li D, Shi Y, Li Z, Ma P, Li P, Chen S, Jin W, Liu S, Chen Q, Gao Q, Zhu L, Xu J, Zhu M, Wang M, Liang K, Zhao L, Xu H, Dong K, Li Q, Cheng X, Chen J, Guo X. Consensus on potential biomarkers developed for use in clinical tests for schizophrenia. Gen Psych 2022;35:e100685. [DOI: 10.1136/gpsych-2021-100685] [Reference Citation Analysis]
7 Lestra V, Romeo B, Martelli C, Benyamina A, Hamdani N. Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis. Schizophr Res 2022;246:175-86. [PMID: 35785580 DOI: 10.1016/j.schres.2022.06.026] [Reference Citation Analysis]
8 Hajj A, Obeid S, Sahyoun S, Haddad C, Azar J, Rabbaa Khabbaz L, Hallit S. Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study. Int J Mol Sci 2019;20:E4753. [PMID: 31557839 DOI: 10.3390/ijms20194753] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
9 Theoharides TC, Tsilioni I, Bawazeer M. Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome. Front Cell Neurosci 2019;13:353. [PMID: 31427928 DOI: 10.3389/fncel.2019.00353] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
10 Ferrari M, Godio M, Martini S, Callegari C, Cosentino M, Marino F. Effect of quetiapine on inflammation and immunity: a systematic review. Int J Psychiatry Clin Pract 2022;:1-12. [PMID: 35913757 DOI: 10.1080/13651501.2022.2101928] [Reference Citation Analysis]
11 Ullah I, Awan HA, Aamir A, Diwan MN, de Filippis R, Awan S, Irfan M, Fornaro M, Ventriglio A, Vellante F, Pettorruso M, Martinotti G, Di Giannantonio M, De Berardis D. Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease. Int J Mol Sci 2021;22:13032. [PMID: 34884840 DOI: 10.3390/ijms222313032] [Reference Citation Analysis]
12 Caruso G, Grasso M, Fidilio A, Tascedda F, Drago F, Caraci F. Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia. Pharmaceuticals (Basel) 2020;13:E457. [PMID: 33322693 DOI: 10.3390/ph13120457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Lin GC, Küng E, Smajlhodzic M, Domazet S, Friedl HP, Angerer J, Wisgrill L, Berger A, Bingle L, Peham JR, Neuhaus W. Directed Transport of CRP Across In Vitro Models of the Blood-Saliva Barrier Strengthens the Feasibility of Salivary CRP as Biomarker for Neonatal Sepsis. Pharmaceutics 2021;13:256. [PMID: 33673378 DOI: 10.3390/pharmaceutics13020256] [Reference Citation Analysis]
14 Wang C, Zhang T, He L, Fu JY, Deng HX, Xue XL, Chen BT. Bacterial Translocation Associates With Aggression in Schizophrenia Inpatients. Front Syst Neurosci 2021;15:704069. [PMID: 34658801 DOI: 10.3389/fnsys.2021.704069] [Reference Citation Analysis]
15 Tsai IC, Hsu CW, Chang CH, Tseng PT, Chang KV. The Effect of Curcumin Differs on Individual Cognitive Domains across Different Patient Populations: A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel) 2021;14:1235. [PMID: 34959636 DOI: 10.3390/ph14121235] [Reference Citation Analysis]
16 Morcuende A, Navarrete F, Nieto E, Manzanares J, Femenía T. Inflammatory Biomarkers in Addictive Disorders. Biomolecules 2021;11:1824. [PMID: 34944470 DOI: 10.3390/biom11121824] [Reference Citation Analysis]
17 de Menezes Galvão AC, Almeida RN, de Sousa GM Jr, Leocadio-Miguel MA, Palhano-Fontes F, de Araujo DB, Lobão-Soares B, Maia-de-Oliveira JP, Nunes EA, Hallak JEC, Schuch FB, Sarris J, Galvão-Coelho NL. Pathophysiology of Major Depression by Clinical Stages. Front Psychol 2021;12:641779. [PMID: 34421705 DOI: 10.3389/fpsyg.2021.641779] [Reference Citation Analysis]
18 Krefft M, Frydecka D, Zalsman G, Krzystek-Korpacka M, Śmigiel R, Gębura K, Bogunia-Kubik K, Misiak B. A pro-inflammatory phenotype is associated with behavioural traits in children with Prader-Willi syndrome. Eur Child Adolesc Psychiatry 2021;30:899-908. [PMID: 32495042 DOI: 10.1007/s00787-020-01568-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
19 Miola A, Dal Porto V, Tadmor T, Croatto G, Scocco P, Manchia M, Carvalho AF, Maes M, Vieta E, Sambataro F, Solmi M. Increased C-reactive protein concentration and suicidal behavior in people with psychiatric disorders: A systematic review and meta-analysis. Acta Psychiatr Scand 2021;144:537-52. [PMID: 34292580 DOI: 10.1111/acps.13351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
20 Li M, Qiu Y, Zhang J, Zhang Y, Liu Y, Zhao Y, Jia Q, Fan X, Li J. Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2022. [PMID: 35037116 DOI: 10.1007/s00406-021-01359-4] [Reference Citation Analysis]
21 Lin BD, Alkema A, Peters T, Zinkstok J, Libuda L, Hebebrand J, Antel J, Hinney A, Cahn W, Adan R, Luykx JJ. Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study. Int J Epidemiol 2019;48:1505-14. [PMID: 31504541 DOI: 10.1093/ije/dyz176] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
22 Bigseth TT, Engh JA, Egeland J, Andersen E, Andreassen OA, Bang-Kittilsen G, Falk RS, Holmen TL, Lindberg M, Mordal J, Nielsen J, Steen NE, Ueland T, Vang T, Fredriksen M. Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms. BMC Psychiatry 2021;21:527. [PMID: 34702245 DOI: 10.1186/s12888-021-03522-6] [Reference Citation Analysis]
23 Gómez-Rubio P, Trapero I. The Effects of Exercise on IL-6 Levels and Cognitive Performance in Patients with Schizophrenia. Diseases 2019;7:E11. [PMID: 30678202 DOI: 10.3390/diseases7010011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Castellano JM, Garcia-Rodriguez S, Espinosa JM, Millan-Linares MC, Rada M, Perona JS. Oleanolic Acid Exerts a Neuroprotective Effect Against Microglial Cell Activation by Modulating Cytokine Release and Antioxidant Defense Systems. Biomolecules. 2019;9. [PMID: 31683841 DOI: 10.3390/biom9110683] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
25 Osimo EF, Baxter L, Stochl J, Perry BI, Metcalf SA, Kunutsor SK, Laukkanen JA, Wium-Andersen MK, Jones PB, Khandaker GM. Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies. NPJ Schizophr 2021;7:31. [PMID: 34050185 DOI: 10.1038/s41537-021-00161-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Kroken RA, Sommer IE, Steen VM, Dieset I, Johnsen E. Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics. Front Psychiatry. 2018;9:753. [PMID: 30766494 DOI: 10.3389/fpsyt.2018.00753] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
27 Fathian F, Gjestad R, Kroken RA, Løberg E, Reitan SK, Fleichhacker WW, Rettenbacher M, Larsen TK, Joa I, Stabell LA, Kjelby E, Sinkevicute I, Alisauskiene R, Steen VM, Johnsen E. Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis. Schizophrenia Research 2022;241:174-83. [DOI: 10.1016/j.schres.2022.01.049] [Reference Citation Analysis]
28 Romeo B, Lestra V, Martelli C, Benyamina A, Hamdani N. Cannabis Cessation, Inflammatory Markers and Schizophrenia. J Dual Diagn 2022;:1-9. [PMID: 34985404 DOI: 10.1080/15504263.2021.2013697] [Reference Citation Analysis]
29 Fournier A, Mondillon L, Luminet O, Canini F, Mathieu N, Gauchez AS, Dantzer C, Bonaz B, Pellissier S. Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome. Front Psychiatry 2020;11:229. [PMID: 32300314 DOI: 10.3389/fpsyt.2020.00229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Morrens M, Overloop C, Coppens V, Loots E, Van Den Noortgate M, Vandenameele S, Leboyer M, De Picker L. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis. Mol Psychiatry 2022. [PMID: 35484245 DOI: 10.1038/s41380-022-01582-y] [Reference Citation Analysis]
31 Vasileva SS, Tucker J, Siskind D, Eyles D. Does the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia? Expert Opin Drug Saf 2022. [PMID: 35189774 DOI: 10.1080/14740338.2022.2042251] [Reference Citation Analysis]
32 Dion-Albert L, Bandeira Binder L, Daigle B, Hong-Minh A, Lebel M, Menard C. Sex differences in the blood-brain barrier: implications for mental health. Front Neuroendocrinol 2022;:100989. [PMID: 35271863 DOI: 10.1016/j.yfrne.2022.100989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Pan LH, Qian M, Qu W, Tang Q, Yan Y. Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function. Neuropsychiatr Dis Treat 2020;16:2891-7. [PMID: 33293814 DOI: 10.2147/NDT.S284149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]